Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection in an Italian cohort in Marche Region, Italy
- PMID: 33682801
- PMCID: PMC7975922
- DOI: 10.23750/abm.v92i1.10847
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection in an Italian cohort in Marche Region, Italy
Abstract
Background and aim: The COVID-19 is an infectious disease caused by the novel coronavirus SARS-CoV-2, declared a public health emergency by the World Health Organization. In this study, we evaluated the seroconversion of SARS-CoV-2 antibodies to find predictors of infection in terms of symptoms, health status, and professions.
Methods: Serological samples of 341 volunteers in a cohort in Marche Region, Italy, were analyzed for the presence of IgM and/or IgG immunoglobulins specific for the SARS-CoV-2. Contextually, an anamnestic questionnaire was administered. The binary logistic regression analysis was used to find the predictors of seroconversion.
Results: Forty-nine subjects (14.4 %) were found positive, without significant differences between gender and age groups. The predictors identified inside the variable categories "symptoms," "risk factors" (smoking habit and established pathologies), and "professions" were the loss of taste and smell (OR, 8.563), cardiovascular diseases (OR, 2.912), and policeman profession (OR, 3.875), respectively.
Conclusions: Although the limited number of subjects recruited in this study, our results could give important findings to be considered for planning preventive strategies in the view of the next COVID-19 waves.
Conflict of interest statement
Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.
Similar articles
-
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119. Epidemiol Prev. 2020. PMID: 33412811 Italian.
-
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.Blood Transfus. 2021 May;19(3):181-189. doi: 10.2450/2021.0324-20. Epub 2021 Feb 3. Blood Transfus. 2021. PMID: 33539289 Free PMC article.
-
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.Clin Microbiol Infect. 2021 Apr;27(4):633.e1-633.e7. doi: 10.1016/j.cmi.2020.11.013. Epub 2020 Nov 28. Clin Microbiol Infect. 2021. PMID: 33253941 Free PMC article.
-
Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data.Cancer Treat Rev. 2020 Nov;90:102102. doi: 10.1016/j.ctrv.2020.102102. Epub 2020 Sep 1. Cancer Treat Rev. 2020. PMID: 32947121 Free PMC article. Review.
-
Seroprevalence of Immunoglobulin M and G Antibodies against SARS-CoV-2 Virus: A Systematic Review and Meta-Analysis Study.Iran J Immunol. 2021 Mar;18(1):34-46. doi: 10.22034/iji.2021.87723.1824. Iran J Immunol. 2021. PMID: 33787512
Cited by
-
Seroprevalence of SARS-CoV-2 in a Large Cohort of Italian Police Officers.Int J Environ Res Public Health. 2021 Nov 20;18(22):12201. doi: 10.3390/ijerph182212201. Int J Environ Res Public Health. 2021. PMID: 34831958 Free PMC article.
-
SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdown.Sci Rep. 2021 Nov 3;11(1):21612. doi: 10.1038/s41598-021-00990-4. Sci Rep. 2021. PMID: 34732800 Free PMC article.
-
Can smoking prevalence explain COVID-19 indicators (cases, mortality, and recovery)? A comparative study in OECD countries.Environ Sci Pollut Res Int. 2022 Aug;29(36):55302-55310. doi: 10.1007/s11356-022-21240-8. Epub 2022 Jun 10. Environ Sci Pollut Res Int. 2022. PMID: 35688981 Free PMC article.
-
Impact of Two Different Recruitment Procedures (Random vs. Volunteer Selection) on the Results of Seroepidemiological Study (SARS-CoV-2).Int J Environ Res Public Health. 2021 Sep 21;18(18):9928. doi: 10.3390/ijerph18189928. Int J Environ Res Public Health. 2021. PMID: 34574850 Free PMC article.
-
Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination.Vaccines (Basel). 2022 Mar 23;10(4):491. doi: 10.3390/vaccines10040491. Vaccines (Basel). 2022. PMID: 35455240 Free PMC article.
References
-
- WHO. Coronavirus disease (COVID-19) outbreak [Internet] 2020 [cited 2020 Mar 4] Available from: http://www.who.int/%0Aemergencies/diseases/novel-coronavirus-2019 .
-
- Dimcheff DE, Schildhouse RJ, Hausman MS, Vincent BM, Markovitz E, Chensue SW, et al. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection Among VA Healthcare System Employees Suggests Higher Risk of Infection When Exposed to SARS-CoV-2 Outside of the Work Environment. Infect Control Hosp Epidemiol [Internet] 2020 Sep 23 [cited 2020 Oct 8]:1–25. Available from: https://pubmed.ncbi.nlm.nih.gov/32962771/ - PMC - PubMed
-
- Riccò M, Ferraro P, Gualerzi G, Ranzieri S, Bragazzi NL, Balzarini F, et al. Point-of-care diagnostic of sars-cov-2: Knowledge, attitudes, and perceptions (KAP) of medical workforce in italy. Acta Biomed [Internet] 2020 [cited 2020 Nov 6];91(2):57–67. Available from: https://pubmed.ncbi.nlm.nih.gov/32420926/ - PMC - PubMed
-
- Cacciapaglia G, Cot C, Sannino F. Second wave COVID-19 pandemics in Europe: a temporal playbook. Sci Rep [Internet] 2020 Dec 1 [cited 2020 Oct 8];10(1) Available from: https://pubmed.ncbi.nlm.nih.gov/32968181/ - PMC - PubMed
-
- Middleton J, Lopes H, Michelson K, Reid J. Planning for a second wave pandemic of COVID-19 and planning for winter: A statement from the Association of Schools of Public Health in the European Region [Internet] International Journal of Public Health Springer. 2020 [cited 2020 Oct 8] Available from: https://pubmed.ncbi.nlm.nih.gov/32857238/ - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous